Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

Panagiotis Paliogiannis, Alessandro G. Fois, Salvatore Sotgia, Arduino A. Mangoni, Elisabetta Zinellu, Pietro Pirina, Silvia Negri, Ciriaco Carru, Angelo Zinellu

Source: Eur Respir Rev, 27 (147) 170113; 10.1183/16000617.0113-2017
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Panagiotis Paliogiannis, Alessandro G. Fois, Salvatore Sotgia, Arduino A. Mangoni, Elisabetta Zinellu, Pietro Pirina, Silvia Negri, Ciriaco Carru, Angelo Zinellu. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev, 27 (147) 170113; 10.1183/16000617.0113-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
T-cell biology and eosinophils in asthma: clinical implications
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019


Neutrophil to lymphocyte ratio and severity of COPD : prospective study
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Year: 2009



Laboratory investigations of infection in COPD: current best practice and future possibilities
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008



Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019


Emerging concepts in outcome assessment for COPD clinical trials
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007

Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
Source: Eur Respir J 2016; 47: 388-389
Year: 2016


Future prospects of translational and clinical eosinophil research
Source: Eur Respir Monogr 2022; 95: 253-262
Year: 2022


A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015



What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 889; 10.1183/20734735.0301-2019
Year: 2020



Lung function trajectory research: historical perspective and future prospects
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021



COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
Source: Eur Respir Rev, 29 (158) 200199; 10.1183/16000617.0199-2020
Year: 2020



Early detection of COPD in general practice: preliminary observations
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point
Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD
Year: 2008